Covestor’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
11
-8
-42% -$89 ﹤0.01% 2398
2026
Q2
$0 Buy
19
+14
+280% +$424 ﹤0.01% 2504
2026
Q1
$0 Buy
+5
New +$133 ﹤0.01% 2290

Other funds holding CAPR

Covestor's CAPR Position: Q3 2026 in Review

Covestor reduced its Capricor Therapeutics (CAPR) stake by 42% in Q3 2026, selling an estimated $89 and leaving 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2398.

Covestor first reported a position in CAPR in Q1 2026 and has held it in 3 quarters since. 106 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Covestor held 11 shares of Capricor Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 8 Capricor Therapeutics shares in Q3 2026, an estimated $89.
  • Capricor Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2398 holding.
  • Covestor first reported a position in Capricor Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 106 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.